CN1939426A - Compound medicine for treating skin scald, insult and sore and its preparation - Google Patents
Compound medicine for treating skin scald, insult and sore and its preparation Download PDFInfo
- Publication number
- CN1939426A CN1939426A CN 200510030065 CN200510030065A CN1939426A CN 1939426 A CN1939426 A CN 1939426A CN 200510030065 CN200510030065 CN 200510030065 CN 200510030065 A CN200510030065 A CN 200510030065A CN 1939426 A CN1939426 A CN 1939426A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- rhizoma polygoni
- skin
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims description 16
- 150000001875 compounds Chemical class 0.000 title description 4
- 238000000034 method Methods 0.000 claims abstract description 29
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 22
- 230000008569 process Effects 0.000 claims abstract description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 25
- 241001465754 Metazoa Species 0.000 claims description 20
- 239000009286 sanguis draxonis Substances 0.000 claims description 19
- 239000008194 pharmaceutical composition Substances 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 17
- 239000012567 medical material Substances 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 16
- 206010040872 skin infection Diseases 0.000 claims description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 11
- 229920001661 Chitosan Polymers 0.000 claims description 11
- 239000003937 drug carrier Substances 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 7
- 239000000084 colloidal system Substances 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 208000036142 Viral infection Diseases 0.000 claims description 5
- 229960000583 acetic acid Drugs 0.000 claims description 5
- 230000009385 viral infection Effects 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- 239000000890 drug combination Substances 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 239000008188 pellet Substances 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 45
- 208000027418 Wounds and injury Diseases 0.000 abstract description 45
- 231100000241 scar Toxicity 0.000 abstract description 9
- 208000025865 Ulcer Diseases 0.000 abstract description 5
- 231100000397 ulcer Toxicity 0.000 abstract description 5
- 244000292697 Polygonum aviculare Species 0.000 abstract description 3
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract description 3
- 230000001524 infective effect Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 62
- 241000700159 Rattus Species 0.000 description 52
- 229940000406 drug candidate Drugs 0.000 description 44
- 230000035876 healing Effects 0.000 description 39
- 239000000546 pharmaceutical excipient Substances 0.000 description 23
- 239000013641 positive control Substances 0.000 description 19
- 239000002674 ointment Substances 0.000 description 18
- 208000015181 infectious disease Diseases 0.000 description 14
- 229940079593 drug Drugs 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 239000011248 coating agent Substances 0.000 description 10
- 238000000576 coating method Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 9
- 230000036407 pain Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 210000000589 cicatrix Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 241000219050 Polygonaceae Species 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- 240000000572 Blumea balsamifera Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000001341 Reynoutria japonica Species 0.000 description 3
- 206010072170 Skin wound Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229960002588 cefradine Drugs 0.000 description 3
- RDLPVSKMFDYCOR-UEKVPHQBSA-N cephradine Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CCC=CC1 RDLPVSKMFDYCOR-UEKVPHQBSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000001804 debridement Methods 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 3
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 241000349731 Afzelia bipindensis Species 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010063560 Excessive granulation tissue Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001508687 Mustela erminea Species 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000007766 cera flava Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000001126 granulation tissue Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 238000003475 lamination Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 229910052979 sodium sulfide Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 239000003871 white petrolatum Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000764073 Bistorta paleacea Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241001172538 Daemonorops draco Species 0.000 description 1
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 1
- 241001163443 Daphne giraldii Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 208000003656 Electric Burns Diseases 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000092659 Pleuropterus Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 241000687941 Salvia przewalskii Species 0.000 description 1
- 235000008202 Salvia przewalskii Nutrition 0.000 description 1
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229960003408 cefazolin sodium Drugs 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000002828 fuel tank Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000000811 metacarpophalangeal joint Anatomy 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Embodiment 1 | Embodiment 2 | Embodiment 3 | | |
Radix Polygoni Ciliinerve | 40 | 35 | 90 | 45 |
Rhizoma Polygoni Cuspidati | 15 | 50 | 15 | 18 |
| 10 | 50 | 10 | 15 |
| 10 | 5 | 12 | 8 |
Radix Salviae Miltiorrhizae | 9 | 6 | 10 | |
| 6 | 6 | 10 | |
| 6 | 5 | ||
Process Corium elephatis | 4 | 3 | ||
| 10 | 20 | ||
| 10 | 17 |
Group | The number of rats that heals fully (only) | Complete healing rate (%) |
Excipient matched group investigational agent group moist expose burn ointment positive control | 0 2 0 | 0 20**## 0 |
Group | Basic healing number of rats (only) | Complete healing rate (%) |
Excipient matched group investigational agent group moist expose burn ointment positive control | 5 10 8 | 50 100**## 80 |
Group | Primary trauma area (cm 2) | Healing wounds area (cm2) | ||
The 10th day | The 15th day | The 25th day | ||
The contrast of excipient matched group investigational agent group moist expose burn ointment | 11.53±0.58 11.44±0.76 11.12±0.71 | 1.68±0.51 3.42±0.87** 3.07±0.96** | 2.52±0.97 6.75±1.68** 5.23±1.74** | 3.57±1.63 8.04±2.42** 6.93±2.10** |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100300651A CN100441206C (en) | 2005-09-28 | 2005-09-28 | Compound medicine for treating skin scald, insult and sore and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100300651A CN100441206C (en) | 2005-09-28 | 2005-09-28 | Compound medicine for treating skin scald, insult and sore and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1939426A true CN1939426A (en) | 2007-04-04 |
CN100441206C CN100441206C (en) | 2008-12-10 |
Family
ID=37958128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100300651A Active CN100441206C (en) | 2005-09-28 | 2005-09-28 | Compound medicine for treating skin scald, insult and sore and its preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100441206C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031255A (en) * | 2015-07-12 | 2015-11-11 | 姚静 | Traditional Chinese medicine preparation for abdominal trauma nursing and its preparation method |
CN105920254A (en) * | 2016-06-27 | 2016-09-07 | 王青年 | Hypertrophic scar eliminating reducing liquid |
CN107095912A (en) * | 2017-06-20 | 2017-08-29 | 遵义医学院 | A kind of Ultramicro-powder ointment of Repercusion analgesia and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1087948C (en) * | 1999-07-26 | 2002-07-24 | 吴永春 | Fast-acting burn and scald treating liquid |
-
2005
- 2005-09-28 CN CNB2005100300651A patent/CN100441206C/en active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031255A (en) * | 2015-07-12 | 2015-11-11 | 姚静 | Traditional Chinese medicine preparation for abdominal trauma nursing and its preparation method |
CN105920254A (en) * | 2016-06-27 | 2016-09-07 | 王青年 | Hypertrophic scar eliminating reducing liquid |
CN107095912A (en) * | 2017-06-20 | 2017-08-29 | 遵义医学院 | A kind of Ultramicro-powder ointment of Repercusion analgesia and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN100441206C (en) | 2008-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1840169A (en) | A Chinese medicinal composition and its application in relieving pain and skin itching | |
CN104147533B (en) | A kind of promoting blood circulation, removing blood stasis and relieving pain emulsifiable paste and preparation method thereof | |
CN1281230C (en) | Medicine composition for curing burn, scald and mucocutaneous ulcer | |
CN1939426A (en) | Compound medicine for treating skin scald, insult and sore and its preparation | |
CN1444977A (en) | Medicine combination containing valid part of Ruyi Jinhuangsan and its preparing method | |
CN101028325A (en) | Medicinal composition containing sailonggu, and its preparation and quality control | |
CN108785429A (en) | A kind of external medicine composition and preparation method thereof repaired that has effects that releive | |
CN1634319A (en) | Chinese traditional medicine compound preparation for treating gynecopathy and preparation method thereof | |
CN1259087C (en) | Medicine for treating trauma and sores and its preparing process | |
CN1279952C (en) | Medicine for treating burns and scalds | |
CN101062085A (en) | Condyloma acuminata treating medicine | |
CN1101549A (en) | Herbal medicine health cosmetic series products and its preparing method | |
CN100350934C (en) | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof | |
CN102670863B (en) | Compound propolis composition for treating acariasis of domestic animal and preparation method thereof | |
CN1262285C (en) | Liniment for skin and its preparation | |
CN1215595A (en) | External use medicine for treating soft tissue injury and its producing method | |
CN1526371A (en) | Cosmetics made of cactus, dahurian angelica root and motherwort for treating various skin diseases and its prepn | |
CN101049432A (en) | External Chinese traditional medicine for accelerating wound healing, reducing cicatrisation, and preparation method | |
CN1281238C (en) | External-applied medicine for treating terminal neuritis and preparation thereof | |
CN101732567B (en) | Medicament for treating burns and preparation method thereof | |
CN1125644C (en) | Ointment for treating acne | |
CN1507910A (en) | Medicinal composition for treating apoplexia, and preparing method and use thereof | |
CN100337656C (en) | Medicinal composition for treating burn and scald and its preparation method | |
CN104523910A (en) | Traditional Chinese medicine oral liquid for treating epifolliculitis | |
CN105617259A (en) | Surgical nursing composition capable of promoting wound healing after mammary gland and thyroid operations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: RUNHE BIOLOGICAL MEDICINE SCIENCE AND TECHNOLOGY( Free format text: FORMER OWNER: CHEN ZHONGLIANG Effective date: 20091120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091120 Address after: Guangdong science and Technology Park, Shantou University, Lu Rongsheng, zip code: 515063 Co-patentee after: Chen Zhongliang Patentee after: RUNBIO BIOTECH Co.,Ltd. Address before: Chongqing city Shapingba District Yubei Road, Shimen Street Village 142 1-1 zip code: 400036 Co-patentee before: Zheng Huiyi Patentee before: Chen Zhongliang |
|
CP01 | Change in the name or title of a patent holder |
Address after: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong, 510000 Patentee after: Guangdong Iconas Biomedical Technology Co.,Ltd. Patentee after: Chen Zhongliang Address before: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong, 510000 Patentee before: Guangdong Iconas Biomedical Technology Co.,Ltd. Patentee before: Chen Zhongliang |
|
CP01 | Change in the name or title of a patent holder | ||
CP03 | Change of name, title or address |
Address after: Room 116, Floor 1, Transportation Bureau Building, No. 95, Yingbin Avenue, Huacheng Street, Huadu District, Guangzhou, Guangdong, 510000 Patentee after: Guangdong Iconas Biomedical Technology Co.,Ltd. Patentee after: Chen Zhongliang Address before: 515063 Lu Rongsheng Science Park, University of Guangdong, Shantou Patentee before: RUNBIO BIOTECH Co.,Ltd. Patentee before: Chen Zhongliang |
|
CP03 | Change of name, title or address |